HCmed Innovations CoTPE:6934 -2.16%11 PS Ratio is 24.91 as of Jul. 06, 2026, which is 78% above its 10-year median of 14.01. GuruFocus rates TPE:6934 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, HCmed Innovations Co ranks worse than 92.67% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, HCmed Innovations Co's share price is NT$68.00.
HCmed Innovations Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$2.73. Hence, HCmed Innovations Co's PS Ratio for today is 24.91.
The historical rank and industry rank for HCmed Innovations Co's PS Ratio or its related term are showing as below:
TPE:6934'
s PS Ratio Range Over the Past 10 Years
Min: 8.76 Med: 14.01 Max: 154.92
Current: 24.91
During the past 5 years, HCmed Innovations Co's highest PS Ratio was 154.92. The lowest was 8.76. And the median was 14.01.
TPE:6934's PS Ratio is ranked worse than 92.67% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs TPE:6934: 24.91
During the past 5 years, HCmed Innovations Co's highest 3-Year average Revenue per Share Growth Rate was 118.70% per year. The lowest was 15.50% per year. And the median was 67.10% per year.
Back to Basics: PS Ratio
HCmed Innovations Co (TPE:6934) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
HCmed Innovations Co PS Ratio Related Terms
HCmed Innovations Co PS Ratio Historical Data
* Premium members only.
The historical data trend for HCmed Innovations Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, HCmed Innovations Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HCmed Innovations Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, HCmed Innovations Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where HCmed Innovations Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
HCmed Innovations Co's Share Price of today is NT$68.00. HCmed Innovations Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2.73.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
HCmed Innovations Co (TPE:6934) has a PS Ratio of 24.91 as of Jul. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on HCmed Innovations Co and its competitors. This is 78% above median its historical median of 14.01. Over the past decade, HCmed Innovations Co's PS Ratio has ranged from 8.76 to 154.92. According to the industry distribution chart, HCmed Innovations Co ranks #746 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 92.7%.
Is HCmed Innovations Co's PS Ratio too high?
HCmed Innovations Co's current PS Ratio of 24.91 is 78% above median its 10-year median of 14.01. Over the past 10 years, this metric has ranged from a low of 8.76 to a high of 154.92. The Medical Devices & Instruments industry median PS Ratio is 2.94. HCmed Innovations Co's value of 24.91 is 747.3% above this industry median. Based on the distribution chart, HCmed Innovations Co ranks #746 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, HCmed Innovations Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does HCmed Innovations Co's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HCmed Innovations Co ranks #746 out of 805 companies for PS Ratio. This places HCmed Innovations Co in the lower half of its industry. The industry median PS Ratio is 2.94. HCmed Innovations Co's value of 24.91 is 747.3% above this benchmark. Historically, HCmed Innovations Co's own PS Ratio has ranged from 8.76 to 154.92 over the past decade. While the company's 10-year median is 14.01 vs. the industry median of 2.94, HCmed Innovations Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HCmed Innovations Co's current PS Ratio of 24.91 is 747.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on HCmed Innovations Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCmed Innovations Co's current PS Ratio is 24.91, which is 78% above median its own 10-year median of 14.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCmed Innovations Co stock overvalued right now?
HCmed Innovations Co (TPE:6934) has a current PS Ratio of 24.91. The current PS Ratio is 24.91, which is 78% above median its 10-year median of 14.01 and 747.3% above the Medical Devices & Instruments industry median of 2.94. HCmed Innovations Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For HCmed Innovations Co (TPE:6934), the current PS Ratio is 24.91 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HCmed Innovations Co Ltd is engaged in designing, developing, manufacturing and selling drug delivery system. It is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product includes Pulmogine. Geographically, the company operates in America, Europe, Asian and African regions.
11GF Score
Get the complete analysis for TPE:6934
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6934 has been successfully added to your 
